CCT Approval definition

CCT Approval means the approval sought from the independent shareholders at the extraordinary general meeting of the Company held on 21 May 2009 (the “EGM”) for acquisition of Connected Debt Securities pursuant to the relevant Master Agreements and subject to the limitations set out in the Master Agreements.
CCT Approval means the approval sought from the independent shareholders at the annual general meeting of the Company held on 27 May 2010 (the “2010 AGM”) for acquisition of Connected Debt Securities pursuant to the relevant Master Agreements and subject to the limitations set out in the Master Agreements and the resolutions passed at the 2010 AGM.
CCT Approval the approval to be sought from the Independent Shareholders at the AGM for acquisition of the Connected Debt Securities pursuant to the Master Agreement; “CCT Relevant Period” the 12-month period commencing on the date of the AGM at which the CCT Approval is granted; “Circular” the circular to be despatched to Shareholders as soon as practicable containing, among other things, details of the Master Agreement in connection with the acquisitions of Connected Debt Securities, the recommendation of the Independent Board Committee, and the advice from the Independent Financial Adviser to the Independent Board Committee and the Independent Shareholders, together with a notice convening the AGM to approve, among other things, the Master Agreement;

Examples of CCT Approval in a sentence

  • We further consider that the terms of the Master Agreements and the CCT Approval (including the Cap) are fair and reasonable so far as the Independent Shareholders are concerned and in the interests of the Company and the Shareholders as a whole.

  • Somerley has been appointed as the Independent Financial Adviser to advise us and the Independent Shareholders in connection with the respective terms of the Master Agreements and the CCT Approval.

  • The CCT Approval will allow the Group to acquire bonds, notes, commercial paper or other similar debt instruments issued or to be issued by CKH or HSE or any of their respective subsidiaries subject to the cap (“Cap”) applicable to the transactions contemplated under the Master Agreements and certain limitations as set out below.

  • Having taken into account the respective terms of the Master Agreements and the advice of Somerley, we consider the Master Agreements and the CCT Approval sought to be on normal commercial terms and fair and reasonable and in the interests of the Company and the Shareholders as a whole.

  • As it would be imprudent to put all or even a majority of Group’s liquidity into such debt securities, protections and limitations are proposed in the resolution for the CCT Approval to be sought from the Independent Shareholders with a view to setting a sound framework for a liquidity investment policy applicable to Connected Debt Securities which may be acquired in the CCT Relevant Period which should improve the Group’s returns while keeping increased risks within prudent limits.

  • Although the proposed acquisition of the 2014/2019 Notes would have complied with the terms and basis for acquisition of HSE Connected Debt Securities within the CCT Approval, as the CCT Relevant Period and the HSE Master Agreement has yet to commence, the debt securities underlying the 2014/2019 Notes to be acquired will not form part of the HSE Connected Debt Securities, the subject matter of the CCT Approval.

  • AGM The CCT Approval will be sought from the Independent Shareholders at the AGM.

  • Sir Michael David KADOORIE, Messrs Holger KLUGE, OR Ching Fai, Raymond and WONG Chung Hin, has been established to give an opinion to the Independent Shareholders as to whether the respective terms of the Master Agreements and the CCT Approval (including the Cap) are fair and reasonable so far as the Independent Shareholders are concerned and in the interests of the Company and the Shareholders as a whole.

  • By virtue of their respective interests in the Master Agreements described above, CKH, Messrs Li Ka-shing and Li Tzar Kuoi, Victor and their respective associates will abstain from voting at the EGM on the relevant resolution proposed to be passed to approve and ratify the relevant Master Agreement and grant the CCT Approval.

  • The Independent Board Committee has been established to provide a recommendation to the Independent Shareholders in respect of the terms of the Master Agreement based on the advice of an independent financial adviser of the Company to be appointed to advise the Independent Board Committee and the Independent Shareholders in respect of the terms of the Master Agreement and of the CCT Approval.


More Definitions of CCT Approval

CCT Approval means the approval sought from the independent shareholders at the annual general meeting of the Company held on

Related to CCT Approval

  • Product Approval means the approval of a Governmental Authority necessary for the marketing and sale of the Product in a given country or regulatory jurisdiction, which may include the approval of an MAA (but shall not include any Pricing Approvals).

  • CPUC Approval means a final and non-appealable order of the CPUC, without conditions or modifications unacceptable to the Parties, or either of them, which contains the following terms:

  • IRB approval means the determination of the IRB that the research has been reviewed and may be conducted at an institution within the constraints set forth by the IRB and by other institutional and federal requirements.

  • MAA Approval means approval by the EMEA of a marketing authorization application (“MAA”) filed with the EMEA for the applicable Licensed Product under the centralized European procedure. If the centralized EMEA filing procedure is not used, MAA Approval shall be achieved upon the first Approval for the applicable Licensed Product in any two of the following countries: France, Germany, Italy, Spain or the United Kingdom.

  • Product Approval(s) means any approvals, registrations, permits, licenses, consents, authorizations, and other approvals, and pending applications and requests therefor, required by applicable Agencies related to the research, Development, manufacture, distribution, finishing, packaging, marketing, sale, storage or transport of a Product within the United States of America, and includes, without limitation, all approvals, registrations, licenses or authorizations granted in connection with any Application related to that Product.

  • Requisite Approval means the affirmative vote of the holders of at least a majority of the shares of outstanding Company Common Stock and outstanding Company Preferred Stock voting as a single class.

  • NDA Approval means the Approval of an NDA by the FDA for a Product in the U.S.

  • Development approval means any written authorization from a

  • Project Approvals means all approvals, consents, waivers, orders, agreements, authorizations, permits and licenses required under Applicable Laws or under the terms of any restriction, covenant, easement or agreement affecting all or any applicable Phase of the Project, or otherwise necessary or desirable for the ownership, acquisition, construction, development, equipping, use or operation of the Project.

  • FCC Approval means the FCC’s grant of the FCC Applications; provided that the possibility that an appeal, request for stay, or petition for rehearing or review by a court or administrative agency may be filed with respect to such grant, or that the FCC may reconsider or review such grant on its own authority, shall not prevent such grant from constituting FCC Approval for purposes of the Plan.

  • Requisite Regulatory Approvals has the meaning set forth in Section 7.01(b).

  • HSR Approval means expiration of all applicable waiting periods under the HSR Act (including any voluntary agreed extensions) or earlier termination thereof.

  • CFIUS Approval means that any of the following shall have occurred: (a) the review period under the DPA commencing on the date that a CFIUS Notice is accepted by CFIUS shall have expired and Xxx, on the one hand, and Polaris, on the other hand, shall have received written notice from CFIUS to the effect that such review has been concluded and that either the Contemplated Transactions do not constitute a “covered transaction” under the DPA or there are no unresolved national security concerns, and all action under the DPA is concluded with respect to the Contemplated Transactions, (b) an investigation under the DPA shall have been commenced after such review period and CFIUS shall have determined to conclude all action under the DPA without sending a report to the President of the United States, and Xxx, on the one hand, and Polaris, on the other hand, shall have received written notice from CFIUS that either the Contemplated Transactions do not constitute a “covered transaction” under the DPA or there are no unresolved national security concerns, and all action under the DPA is concluded with respect to the Contemplated Transactions, or (c) CFIUS shall have sent a report to the President of the United States requesting the President’s decision and either (i) the President shall have announced a decision not to take any action to suspend or prohibit the Contemplated Transactions or, (ii) the period under the DPA during which the President may announce his decision to take action to suspend, prohibit or place any limitations on the Contemplated Transactions shall have expired without any such action being threatened, announced or taken.

  • Competition Act Approval means, in respect of the Arrangement, the occurrence of one of the following:

  • Pre-approval means written notification via a pre-approval letter to Customer that Ameren Illinois has reviewed Customer's Application and determined that the project meets the program eligibility requirements for a maximum pre-approved incentive amount if the project is completed by the estimated completion date and all final application paperwork is submitted and approved.

  • Regulatory Approval means, with respect to a Product in any country or jurisdiction, any approval (including where required, pricing and reimbursement approvals), registration, license or authorization from a Regulatory Authority in a country or other jurisdiction that is necessary to market and sell such Product in such country or jurisdiction.

  • Development Approvals means all permits and other entitlements for use subject to approval or issuance by CITY in connection with development of the Property including, but not limited to:

  • Government Approval means (a) any authorization, consent, approval, license, lease, ruling, permit, tariff, rate, certification, waiver, exemption, filing, variance, claim, order, judgment or decree of, by or with, (b) any required notice to, (c) any declaration of or with or (d) any registration by or with, any Government Authority.

  • Regulatory Approvals with respect to the Warrantholder, means, to the extent applicable and required to permit the Warrantholder to exercise this Warrant for shares of Common Stock and to own such Common Stock without the Warrantholder being in violation of applicable law, rule or regulation, the receipt of any necessary approvals and authorizations of, filings and registrations with, notifications to, or expiration or termination of any applicable waiting period under, the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended, and the rules and regulations thereunder.

  • FDA Approval means with respect to the Product, a Regulatory Approval by the FDA for the commercial use of the Product in the United States.

  • Marketing Approval means all approvals, licenses, registrations or authorizations of the Regulatory Authority in a country, necessary for the manufacture, use, storage, import, marketing and sale of a Product in such country.

  • Price Approval means, in any country where a Governmental Authority authorizes reimbursement for, or approves or determines pricing for, pharmaceutical products, receipt (or, if required to make such authorization, approval or determination effective, publication) of such reimbursement authorization or pricing approval or determination (as the case may be).

  • Reimbursement Approval means an approval, agreement, determination, or other decision by the applicable Governmental Authority that establishes prices charged to end-users for pharmaceutical or biologic products at which a particular pharmaceutical or biologic product will be reimbursed by the Regulatory Authorities or other applicable Governmental Authorities in the Territory.

  • Disclosure Statement Approval Order means the Final Order approving, among other things, the adequacy of the Disclosure Statement pursuant to section 1125 of the Bankruptcy Code.

  • Required Regulatory Approvals means the Seller Required Regulatory Approvals and the Buyer Required Regulatory Approvals.

  • Regulatory Approval Application means an application to seek regular or expedited Regulatory Approval of the Licensed Product for sale or marketing in any country(ies) or Region(s) in the Territory, as defined in the applicable Laws and filed with the Regulatory Authority of such country(ies) or Region(s).